What is the future of pharmaceutical sales? Jiang Xiaomeng said: to change to deal with the market
Release time:
2020-08-17
Pharmaceutical sales in the future how to go?
Jiang Xiaomeng said: to change to deal with the market
News 7# July 30 - 31 , pharmaceutical sales company held a first half of the work summary meeting, all sales staff gathered together to summarize the work of the first half of the year, analyze the existing problems, discuss the second half of the work plan and initiatives. Jiang Xiaomeng, chairman of the group company, asked at the meeting: "to deal with the changing pharmaceutical market with transformative thinking and measures." At the
meeting, Zhou Wenyi, general manager of the pharmaceutical sales company, summarized the work in the first half of the year from the aspects of sales model adjustment, team building, production and marketing connection and communication, business training, product listing and promotion, analyzed the existing problems and causes, put forward countermeasures, and expounded the work ideas and objectives for the second half of the year. Xu Junxiong, executive deputy general manager of the pharmaceutical sales company, and Zhang Jinhui, deputy general manager, also summarized the work of the terminal sales and sales control department in the first half of the year, and arranged and deployed the work in the second half of the year. Jiang Xiaomeng, chairman of the group company, and Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, attended the meeting and put forward requirements for sales work. Huang Jinlong requires sales companies to strictly implement the elimination mechanism, strengthen academic promotion and training, and continuously introduce mature sales teams. Regional managers should pay attention to the collection of information from all over the country and make overall arrangements. Eliminate the blank market at the prefecture level and achieve the goal of responsibility.Jiang Xiaomeng said at the meeting that in recent years, there have been frequent policies in the pharmaceutical industry, and the market has changed rapidly. Price will be the ultimate killer of enterprises. He asked the pharmaceutical sales team to deal with the changing pharmaceutical market with innovative thinking and measures: to deal with the changes in the market with the change of ideas, sales staff should change their traditional thinking and fluke psychology, and face the future trend of the market calmly, plan in advance; to respond to market changes with changes in the organizational structure, sales companies must establish a terminal sales team with commercial control as the purpose and hired commercial representatives as the mainstay, and do a good job in the basic market; to improve their self-ability to respond to the market For changes, sales staff must strengthen self-learning and continuously improve business skills to adapt to the changing market environment. (Reporter
Ni Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page